Literature DB >> 692599

Current concepts in cancer. Receptors in breast cancer.

M E Lippman, J C Allegra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 692599     DOI： 10.1056/NEJM197810262991706

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Intratumoral variations in cytoplasmic estrogen receptor levels in breast cancer.

Authors:  A Lluch; A Antón; F Carbonell; V Alberola; J Carcia-Conde
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

2.  Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.

Authors:  D J Perrault; D M Logan; D J Stewart; V H Bramwell; A H Paterson; E A Eisenhauer
Journal:  Invest New Drugs       Date:  1988-09       Impact factor: 3.850

3.  Oestrogen receptor values and histologic type and grade in breast carcinoma--a three year review.

Authors:  B M Loftus; C E Connolly
Journal:  Ir J Med Sci       Date:  1988-02       Impact factor: 1.568

4.  Cytochemistry of sex steroid receptors: a critique.

Authors:  K S McCarty; D S Reintgen; H F Seigler; K S McCarty
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

5.  Cigarette smoke and the hormonal receptors status in breast cancer.

Authors:  D Ranocchia; L Minelli; M A Modolo
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

6.  Estradiol receptor levels in human breast carcinomas.

Authors:  C E Bird; B Houghton; W Westenbrink; M Tenniswood; E E Sterns; A F Clark
Journal:  Can Med Assoc J       Date:  1981-04-15       Impact factor: 8.262

7.  Estrogen receptors in mammary cancer: correlation with age, menopausal status, and response to therapy.

Authors:  R Johansson; R Vanharanta; J Söderholm
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

8.  Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: significance in claudin-low breast cancer cells.

Authors:  Abdullah Alsuliman; Dilek Colak; Olfat Al-Harazi; Hanaa Fitwi; Asma Tulbah; Taher Al-Tweigeri; Monther Al-Alwan; Hazem Ghebeh
Journal:  Mol Cancer       Date:  2015-08-07       Impact factor: 27.401

9.  Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.

Authors:  Torsten O Nielsen; Samuel C Y Leung; David L Rimm; Andrew Dodson; Balazs Acs; Sunil Badve; Carsten Denkert; Matthew J Ellis; Susan Fineberg; Margaret Flowers; Hans H Kreipe; Anne-Vibeke Laenkholm; Hongchao Pan; Frédérique M Penault-Llorca; Mei-Yin Polley; Roberto Salgado; Ian E Smith; Tomoharu Sugie; John M S Bartlett; Lisa M McShane; Mitch Dowsett; Daniel F Hayes
Journal:  J Natl Cancer Inst       Date:  2021-07-01       Impact factor: 13.506
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.